In addition, concerning COVID-19 related vascular damage, it should be noted that, in contrast to preclinical evidence, human studies have shown either a neutral [39] or a detrimental [40] effect of DPP4 blockage on endothelial function in the setting of diabetes. Here, DPP4 is linked to COVID-19.